Page 9 - Discovery Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

I think this UK small-cap stock is just getting started More on: Sensyne Health  (LSE: SENS) and reckon it has lots of potential. The shares have been rising on the back on recent positive news.  I think the company is just getting started and I’d buy the stock in my portfolio. Here’s why. US$12.3 TRILLION out of thin air… And if you click here we’ll show you something that could be key to unlocking 5G’s full potential... Sensyne Health: what does it do? In a nutshell, Sensyne Health is an AIM-listed healthcare company that uses artificial intelligence to analyse data. The compa...

  Oxford, UK; 21 January 2021: Sensyne Health plc (LSE: SENS) ("Sensyne" or the "Company" or the "Group"), the UK Clinical AI company, today announces its Interim Results for the six months ended 31 October 2020.     "I am pleased to report that Sensyne has made significant commercial progress over the past six months and has achieved several key milestones in the development of its research partnerships with NHS Trusts and in its work for leading pharmaceutical companies applying Clinical AI to improve patient care and accelerate life sciences resear...